(SZU) Südzucker - Ratings and Ratios
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE0007297004
Sugar, Ethanol, Starch, Fruit, Ingredients
SZU EPS (Earnings per Share)
SZU Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 18.6% |
| Value at Risk 5%th | 30.1% |
| Reward | |
|---|---|
| Sharpe Ratio | -0.98 |
| Alpha | -20.97 |
| Character | |
|---|---|
| Hurst Exponent | 0.536 |
| Beta | 0.215 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.52% |
| Mean DD | 25.32% |
Description: SZU Südzucker November 10, 2025
Südzucker AG (XETRA:SZU) is a German-based producer of sugar and a diversified food-ingredients group that operates through five business segments: Sugar, Special Products, CropEnergies, Starch, and Fruit. The Sugar segment supplies raw and specialty sugars, glucose syrup, and animal feed; Special Products creates functional ingredients such as dietary fibers, sugar substitutes, and frozen convenience foods; CropEnergies manufactures fuel-grade ethanol, neutral alcohol, and liquid CO₂; Starch offers starches, saccharification products, and related by-products; and Fruit processes fruit preparations, concentrates, and beverage bases.
Key financial highlights (2023) include revenue of roughly €6.1 billion and an adjusted EBITDA margin of about 12 %, reflecting the mix of higher-margin specialty ingredients and lower-margin commodity sugar. The company’s earnings are sensitive to EU sugar price reforms, raw beet-price volatility, and the price spread between ethanol and crude oil, which together drive the CropEnergies profitability.
Sector-level drivers that shape Südzucker’s outlook are the ongoing consumer shift toward reduced-sugar and “clean-label” products-benefiting its Special Products line-and the European Union’s renewable-fuel mandates, which underpin demand for its ethanol output.
For a deeper quantitative view of SZU’s valuation metrics and peer comparison, you might explore the analysis on ValueRay.
SZU Stock Overview
| Market Cap in USD | 2,255m |
| Sub-Industry | Packaged Foods & Meats |
| IPO / Inception | |
| Return 12m vs S&P 500 | -25.42% |
| Analyst Rating | - |
SZU Dividends
| Dividend Yield | 2.11% |
| Yield on Cost 5y | 1.82% |
| Yield CAGR 5y | 45.65% |
| Payout Consistency | 89.4% |
| Payout Ratio | 409.1% |
SZU Growth Ratios
| CAGR | -8.55% |
| CAGR/Max DD Calmar Ratio | -0.20 |
| CAGR/Mean DD Pain Ratio | -0.34 |
| Current Volume | 111k |
| Average Volume | 127.5k |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (-191.0m TTM) > 0 and > 6% of Revenue (6% = 557.8m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA -7.89pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 22.97% (prev 27.46%; Δ -4.49pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 608.0m > Net Income -191.0m (YES >=105%, WARN >=100%) |
| Net Debt (3.47b) to EBITDA (2.21b) ratio: 1.57 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.80 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (204.1m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 80.67% (prev 80.80%; Δ -0.13pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 98.37% (prev 104.9%; Δ -6.55pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -1.55 (EBITDA TTM 2.21b / Interest Expense TTM 119.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.19
| (A) 0.23 = (Total Current Assets 4.80b - Total Current Liabilities 2.67b) / Total Assets 9.24b |
| (B) 0.09 = Retained Earnings (Balance) 859.0m / Total Assets 9.24b |
| (C) -0.02 = EBIT TTM -184.0m / Avg Total Assets 9.45b |
| (D) 0.48 = Book Value of Equity 2.52b / Total Liabilities 5.28b |
| Total Rating: 2.19 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 35.71
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield 0.67% = 0.33 |
| 3. FCF Margin 0.34% = 0.09 |
| 4. Debt/Equity 1.07 = 1.95 |
| 5. Debt/Ebitda 1.57 = 0.82 |
| 6. ROIC - WACC (= -6.69)% = -8.36 |
| 7. RoE -5.76% = -0.96 |
| 8. Rev. Trend -43.59% = -3.27 |
| 9. EPS Trend -77.85% = -3.89 |
What is the price of SZU shares?
As of November 11, 2025, the stock is trading at EUR 9.48 with a total of 111,003 shares traded.
Over the past week, the price has changed by -0.37%, over one month by -4.24%, over three months by -6.14% and over the past year by -14.08%.
Over the past week, the price has changed by -0.37%, over one month by -4.24%, over three months by -6.14% and over the past year by -14.08%.
Is Südzucker a good stock to buy?
No, based on ValueRay´s Fundamental Analyses, Südzucker (XETRA:SZU) is currently (November 2025)
a stock to sell. It has a ValueRay Fundamental Rating of 35.71 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SZU is around 9.06 EUR . This means that SZU is currently overvalued and has a potential downside of -4.43%.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SZU is around 9.06 EUR . This means that SZU is currently overvalued and has a potential downside of -4.43%.
Is SZU a buy, sell or hold?
Südzucker has no consensus analysts rating.
What are the forecasts/targets for the SZU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10.2 | 7.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 9.6 | 1.3% |
SZU Fundamental Data Overview January 01, 1970
Market Cap USD = 2.25b (1.95b EUR * 1.1543 EUR.USD)
Market Cap EUR = 1.95b (1.95b EUR * 1.0 EUR.EUR)
P/E Forward = 15.9744
P/S = 0.222
P/B = 0.599
P/EG = 0.75
Beta = 0.215
Revenue TTM = 9.30b EUR
EBIT TTM = -184.0m EUR
EBITDA TTM = 2.21b EUR
Long Term Debt = 1.43b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.29b EUR (from shortTermDebt, last quarter)
Debt = 3.47b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.47b EUR (from netDebt column, last quarter)
Enterprise Value = 4.79b EUR (1.95b + Debt 3.47b - CCE 626.0m)
Interest Coverage Ratio = -1.55 (Ebit TTM -184.0m / Interest Expense TTM 119.0m)
FCF Yield = 0.67% (FCF TTM 32.0m / Enterprise Value 4.79b)
FCF Margin = 0.34% (FCF TTM 32.0m / Revenue TTM 9.30b)
Net Margin = -2.05% (Net Income TTM -191.0m / Revenue TTM 9.30b)
Gross Margin = 80.67% ((Revenue TTM 9.30b - Cost of Revenue TTM 1.80b) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 100.0%)
Tobins Q-Ratio = 0.52 (Enterprise Value 4.79b / Total Assets 9.24b)
Interest Expense / Debt = 0.92% (Interest Expense 32.0m / Debt 3.47b)
Taxrate = 10.26% (-4.00m / -39.0m)
NOPAT = -165.1m (EBIT -184.0m * (1 - 10.26%)) [loss with tax shield]
Current Ratio = 1.80 (Total Current Assets 4.80b / Total Current Liabilities 2.67b)
Debt / Equity = 1.07 (Debt 3.47b / totalStockholderEquity, last quarter 3.23b)
Debt / EBITDA = 1.57 (Net Debt 3.47b / EBITDA 2.21b)
Debt / FCF = 108.3 (Net Debt 3.47b / FCF TTM 32.0m)
Total Stockholder Equity = 3.32b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.07% (Net Income -191.0m / Total Assets 9.24b)
RoE = -5.76% (Net Income TTM -191.0m / Total Stockholder Equity 3.32b)
RoCE = -3.87% (EBIT -184.0m / Capital Employed (Equity 3.32b + L.T.Debt 1.43b))
RoIC = -3.71% (negative operating profit) (NOPAT -165.1m / Invested Capital 4.46b)
WACC = 2.98% (E(1.95b)/V(5.42b) * Re(6.81%) + D(3.47b)/V(5.42b) * Rd(0.92%) * (1-Tc(0.10)))
Discount Rate = 6.81% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.02%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈337.2m ; Y1≈221.4m ; Y5≈101.2m
Fair Price DCF = 9.75 (DCF Value 1.99b / Shares Outstanding 204.1m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -77.85 | EPS CAGR: -23.18% | SUE: -4.0 | # QB: 0
Revenue Correlation: -43.59 | Revenue CAGR: -3.12% | SUE: -0.04 | # QB: 0
Market Cap EUR = 1.95b (1.95b EUR * 1.0 EUR.EUR)
P/E Forward = 15.9744
P/S = 0.222
P/B = 0.599
P/EG = 0.75
Beta = 0.215
Revenue TTM = 9.30b EUR
EBIT TTM = -184.0m EUR
EBITDA TTM = 2.21b EUR
Long Term Debt = 1.43b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.29b EUR (from shortTermDebt, last quarter)
Debt = 3.47b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.47b EUR (from netDebt column, last quarter)
Enterprise Value = 4.79b EUR (1.95b + Debt 3.47b - CCE 626.0m)
Interest Coverage Ratio = -1.55 (Ebit TTM -184.0m / Interest Expense TTM 119.0m)
FCF Yield = 0.67% (FCF TTM 32.0m / Enterprise Value 4.79b)
FCF Margin = 0.34% (FCF TTM 32.0m / Revenue TTM 9.30b)
Net Margin = -2.05% (Net Income TTM -191.0m / Revenue TTM 9.30b)
Gross Margin = 80.67% ((Revenue TTM 9.30b - Cost of Revenue TTM 1.80b) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 100.0%)
Tobins Q-Ratio = 0.52 (Enterprise Value 4.79b / Total Assets 9.24b)
Interest Expense / Debt = 0.92% (Interest Expense 32.0m / Debt 3.47b)
Taxrate = 10.26% (-4.00m / -39.0m)
NOPAT = -165.1m (EBIT -184.0m * (1 - 10.26%)) [loss with tax shield]
Current Ratio = 1.80 (Total Current Assets 4.80b / Total Current Liabilities 2.67b)
Debt / Equity = 1.07 (Debt 3.47b / totalStockholderEquity, last quarter 3.23b)
Debt / EBITDA = 1.57 (Net Debt 3.47b / EBITDA 2.21b)
Debt / FCF = 108.3 (Net Debt 3.47b / FCF TTM 32.0m)
Total Stockholder Equity = 3.32b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.07% (Net Income -191.0m / Total Assets 9.24b)
RoE = -5.76% (Net Income TTM -191.0m / Total Stockholder Equity 3.32b)
RoCE = -3.87% (EBIT -184.0m / Capital Employed (Equity 3.32b + L.T.Debt 1.43b))
RoIC = -3.71% (negative operating profit) (NOPAT -165.1m / Invested Capital 4.46b)
WACC = 2.98% (E(1.95b)/V(5.42b) * Re(6.81%) + D(3.47b)/V(5.42b) * Rd(0.92%) * (1-Tc(0.10)))
Discount Rate = 6.81% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.02%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈337.2m ; Y1≈221.4m ; Y5≈101.2m
Fair Price DCF = 9.75 (DCF Value 1.99b / Shares Outstanding 204.1m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -77.85 | EPS CAGR: -23.18% | SUE: -4.0 | # QB: 0
Revenue Correlation: -43.59 | Revenue CAGR: -3.12% | SUE: -0.04 | # QB: 0